{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:40:16Z","timestamp":1788921616944,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.intimp.2024.113000","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T13:39:04Z","timestamp":1724765944000},"page":"113000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Nicardipine-chitosan nanoparticles alleviate thioacetamide-induced acute liver injury by targeting NF\u03baB\/NLRP3\/IL-1\u03b2 signaling in rats: Unraveling new roles beyond calcium channel blocking"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1495-0480","authenticated-orcid":false,"given":"Ahmed Y.","family":"Kira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsayed A.","family":"Elmorsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3465-4470","authenticated-orcid":false,"given":"Rabab S.","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Ahmed","family":"Abdel-Reheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4219-2915","authenticated-orcid":false,"given":"Mai Abdallah","family":"Elhemely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noura","family":"El Adle Khalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attalla F.","family":"El-kott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"AlShehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem","family":"Morsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8057-2022","authenticated-orcid":false,"given":"Sally","family":"Negm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8823-8774","authenticated-orcid":false,"given":"Ahmed A.E.","family":"Mourad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4586-8546","authenticated-orcid":false,"given":"Asmaa","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5070-7851","authenticated-orcid":false,"given":"Sameh","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.113000_b0005","series-title":"The Liver: Biology and Pathobiology","author":"Arias","year":"2020"},{"key":"10.1016\/j.intimp.2024.113000_b0010","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399411002110","article-title":"Molecular mechanisms underlying chemical liver injury","volume":"14","author":"Gu","year":"2012","journal-title":"Expert Rev. Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113000_b0015","article-title":"Chemical induced liver injury: types, mechanisms and biomarkers","volume":"6","author":"Sachan","year":"2023","journal-title":"Anatom. Sci."},{"issue":"1_suppl","key":"10.1016\/j.intimp.2024.113000_b0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/0023677215573040","article-title":"Standard operating procedures in experimental liver research: thioacetamide model in mice and rats","volume":"49","author":"Wallace","year":"2015","journal-title":"Lab. Anim"},{"key":"10.1016\/j.intimp.2024.113000_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2023.104093","article-title":"Molecular mechanisms in thioacetamide-induced acute and chronic liver injury models","volume":"99","author":"Ezhilarasan","year":"2023","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113000_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105388","article-title":"Regulation of the NLRP3 inflammasome with natural products against chemical-induced liver injury","volume":"164","author":"Zou","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.intimp.2024.113000_b0035","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/1751-2980.12918","article-title":"Role of NLRP3 inflammasome in liver disease","volume":"21","author":"Al Mamun","year":"2020","journal-title":"J. Dig. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2024.113000_b0040","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.2147\/JIR.S315938","article-title":"The supportive role of NSC328382, a P2X7R antagonist, in enhancing the inhibitory effect of CRID3 on NLRP3 inflammasome activation in rats with dextran sodium sulfate-induced colitis","volume":"14","author":"Saber","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2024.113000_b0045","doi-asserted-by":"crossref","unstructured":"A.B. Rowaiye, O.S. Oluwasunmibare, U.S. Abubakar, P. Aondona, L.C. Emenyeonu, The NLRP3 inflammasome as a target for anti-inflammatory drugs, the NLRP3 inflammasome: an attentive arbiter of inflammatory response (2024) 119.","DOI":"10.2174\/9789815223941124010009"},{"key":"10.1016\/j.intimp.2024.113000_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113409","article-title":"Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK\/NF-\u03baB\/NLRP3 axis: a new paradigm in the rectal therapy of ulcerative colitis","volume":"153","author":"Nasr","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.113000_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112723","article-title":"Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-\u03baB and NLRP3 crosstalk: a novel approach for filling an unmet medical need","volume":"148","author":"Zohny","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2024.113000_b0060","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-023-01318-1","article-title":"Association between hypertension and the prevalence of liver steatosis and fibrosis","volume":"23","author":"Fu","year":"2023","journal-title":"BMC Endocr. Disord."},{"issue":"1","key":"10.1016\/j.intimp.2024.113000_b0065","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2195203","article-title":"Association between dietary inflammation index and hypertension in participants with different degrees of liver steatosis","volume":"55","author":"Wu","year":"2023","journal-title":"Ann. Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.113000_b0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/HYPERTENSIONAHA.119.13419","article-title":"Nonalcoholic fatty liver disease","volume":"75","author":"Zhao","year":"2020","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.intimp.2024.113000_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100892","article-title":"Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease","volume":"28","author":"Liu","year":"2023","journal-title":"Ann. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113000_b0080","first-page":"328","article-title":"Anti-inflammatory effects of L-type calcium channel blockers","volume":"27","author":"Dengi\u0307z","year":"2007","journal-title":"Turkiye Klinikleri J. Med. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2024.113000_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091167","article-title":"Anti-neuroinflammatory effects of the calcium channel blocker nicardipine on microglial cells: implications for neuroprotection","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2024.113000_b0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00210-020-01958-3","article-title":"Effect of nifedipine, a calcium channel blocker, on the generation of nitric oxide and interleukin-1\u03b2 by murine macrophages activated by lipopolysaccharide from Prevotella intermedia","volume":"394","author":"Choe","year":"2021","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113000_b0095","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s10753-020-01215-y","article-title":"Nicardipine inhibits priming of the NLRP3 inflammasome via suppressing LPS-induced TLR4 expression","volume":"43","author":"Chang","year":"2020","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2024.113000_b0100","article-title":"Design, formulation, in-vitro and in-vivo pharmacokinetic evaluation of Nicardipine-nanostructured lipid carrier for transdermal drug delivery system","author":"Avula","year":"2023","journal-title":"Mater. Today: Proc."},{"issue":"4","key":"10.1016\/j.intimp.2024.113000_b0105","first-page":"128","article-title":"Design and in vitro evaluation of sustained release matrix tablets of complexed Nicardipine Hydrochloride","volume":"2","author":"Roy","year":"2010","journal-title":"Int. J. Pharm. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.113000_b0110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jsps.2011.05.004","article-title":"Designing an extended release waxy matrix tablet containing nicardipine\u2013hydroxy propyl \u03b2 cyclodextrin complex","volume":"19","author":"Al-Zein","year":"2011","journal-title":"Saudi Pharm. J."},{"issue":"1","key":"10.1016\/j.intimp.2024.113000_b0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0168-3659(02)00465-0","article-title":"Hydrophilic and hydrophobic cyclodextrins in a new sustained release oral formulation of nicardipine: in vitro evaluation and bioavailability studies in rabbits","volume":"88","author":"Fernandes","year":"2003","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.intimp.2024.113000_b0120","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5425","article-title":"Effect of concomitant oral administration of ethanol on the pharmacokinetics of nicardipine in rats","volume":"36","author":"Jung","year":"2022","journal-title":"Biomed. Chromatogr."},{"issue":"4","key":"10.1016\/j.intimp.2024.113000_b0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1139\/cjpp-2021-0387","article-title":"Clinical efficacy and safety of two concentrations of intravenous nicardipine hydrochloride for nicardipine-related phlebitis in patients with preeclampsia","volume":"100","author":"Ye","year":"2022","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113000_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.105644","article-title":"Navigating liver targeting: fine-tuning chitosan nanocarriers through saccharide modification","author":"Kira","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113000_b0135","article-title":"Azithromycin loaded chitosan nanoparticles preparation and in-vitro characterization","volume":"5","author":"Srag El-Din","year":"2022","journal-title":"Delta Univ. Sci. J."},{"issue":"2","key":"10.1016\/j.intimp.2024.113000_b0140","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/09205063.2023.2279792","article-title":"Exploring the potential of pH-sensitive polymers in targeted drug delivery","volume":"35","author":"Gomte","year":"2024","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.intimp.2024.113000_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1377980","article-title":"Hedgehog signaling is a promising target for the treatment of hepatic fibrogenesis: a new management strategy using itraconazole-loaded nanoparticles","volume":"15","author":"Elmorsy","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113000_b0150","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.3c00542","article-title":"Lactosylated chitosan nanoparticles potentiate the anticancer effects of telmisartan in vitro and in a N-nitrosodiethylamine-induced mice model of hepatocellular carcinoma","author":"Nasr","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.intimp.2024.113000_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2024.112983","article-title":"Advances in chitosan-based drug delivery systems: a comprehensive review for therapeutic applications","author":"Haider","year":"2024","journal-title":"Eur. Polym. J."},{"issue":"11","key":"10.1016\/j.intimp.2024.113000_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28114328","article-title":"A simple method for synthesis of chitosan nanoparticles with ionic gelation and homogenization","volume":"28","author":"Van Bavel","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.113000_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.101732","article-title":"Deferoxamine-loaded transfersomes accelerates healing of pressure ulcers in streptozotocin-induced diabetic rats","volume":"58","author":"El-Gizawy","year":"2020","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113000_b0170","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1208\/s12249-023-02605-9","article-title":"Telmisartan-loaded lactosylated chitosan nanoparticles as a liver specific delivery system: synthesis, optimization and targeting efficiency","volume":"24","author":"Nasr","year":"2023","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.intimp.2024.113000_b0175","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.intimp.2024.113000_b0180","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1155\/2004\/542981","article-title":"High performace liquid chromtographic determination of nicardipine hydrochloride in human plasma","volume":"1","author":"Krishnaiah","year":"2004","journal-title":"J. Chem."},{"issue":"7","key":"10.1016\/j.intimp.2024.113000_b0185","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/cbf.3839","article-title":"Coleus vettiveroides ethanolic root extract protects against thioacetamide-induced acute liver injury in rats","volume":"41","author":"Mohamed Azar","year":"2023","journal-title":"Cell Biochem. Funct."},{"issue":"7","key":"10.1016\/j.intimp.2024.113000_b0190","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/BF01273360","article-title":"Influence of nicardipine, nimodipine and flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazol in mice","volume":"103","author":"Gasior","year":"1996","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"6","key":"10.1016\/j.intimp.2024.113000_b0195","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2024.113000_b0200","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.colsurfa.2015.04.006","article-title":"Preparation of chitosan\u2013TPP nanoparticles using microengineered membranes\u2013effect of parameters and encapsulation of tacrine","volume":"482","author":"Hassani","year":"2015","journal-title":"Colloids Surf. A: Physicochem. Eng. Asp."},{"key":"10.1016\/j.intimp.2024.113000_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119038","article-title":"Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: optimization using Box-Behnken design, stability and in vivo study","volume":"577","author":"Delan","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.intimp.2024.113000_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11092247","article-title":"Celecoxib-loaded cubosomal nanoparticles as a therapeutic approach for staphylococcus aureus in vivo infection","volume":"11","author":"Alshawwa","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.intimp.2024.113000_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11671-017-1853-y","article-title":"Size, stability, and porosity of mesoporous nanoparticles characterized with light scattering","volume":"12","author":"Kaasalainen","year":"2017","journal-title":"Nanoscale Res. Lett."},{"issue":"4","key":"10.1016\/j.intimp.2024.113000_b0220","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3390\/md13041819","article-title":"Stability of chitosan\u2014a challenge for pharmaceutical and biomedical applications","volume":"13","author":"Szyma\u0144ska","year":"2015","journal-title":"Mar. Drugs"},{"issue":"5","key":"10.1016\/j.intimp.2024.113000_b0225","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1248\/bpb.28.882","article-title":"Inhibitory effects of nicardipine to cytochrome P450 (CYP) in human liver microsomes","volume":"28","author":"Nakamura","year":"2005","journal-title":"Biol. Pharm. Bull."},{"issue":"12","key":"10.1016\/j.intimp.2024.113000_b0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.22270\/jddt.v13i12.6134","article-title":"Revolutionizing drug delivery: nicardipine nanosuspension formulation and in-vitro evaluation","volume":"13","author":"Miskan","year":"2023","journal-title":"J. Drug Delivery Therap."},{"issue":"8","key":"10.1016\/j.intimp.2024.113000_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/nano13081302","article-title":"A review of the preparation, characterization, and applications of chitosan nanoparticles in nanomedicine","volume":"13","author":"Jha","year":"2023","journal-title":"Nanomaterials"},{"issue":"4","key":"10.1016\/j.intimp.2024.113000_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28041963","article-title":"Chitosan-based nanoparticles as effective drug delivery systems\u2014a review","volume":"28","author":"Jafernik","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.intimp.2024.113000_b0245","first-page":"6","article-title":"The use of chitosan nanoparticles obtained by ionic gelation method as a drug delivery system","volume":"5","author":"Ismik","year":"2020","journal-title":"J. Mater. Electron. Dev."},{"key":"10.1016\/j.intimp.2024.113000_b0250","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.colsurfb.2015.07.016","article-title":"A rational approach towards the design of chitosan-based nanoparticles obtained by ionotropic gelation","volume":"135","author":"Kleine-Brueggeney","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"2","key":"10.1016\/j.intimp.2024.113000_b0255","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbamcr.2014.11.022","article-title":"Acidic environment activates inflammatory programs in fibroblasts via a cAMP\u2013MAPK pathway","volume":"1853","author":"Riemann","year":"2015","journal-title":"Biochimica et Biophysica Acta (BBA)-Mol. Cell Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.113000_b0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061991","article-title":"Acidosis activation of the proton-sensing GPR4 receptor stimulates vascular endothelial cell inflammatory responses revealed by transcriptome analysis","volume":"8","author":"Dong","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.intimp.2024.113000_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/polym10030267","article-title":"Chitosan and its derivatives for application in mucoadhesive drug delivery systems","volume":"10","author":"Ways","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.intimp.2024.113000_b0270","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/131358","article-title":"Pharmacokinetic delivery and metabolizing rate of nicardipine incorporated in hydrophilic and hydrophobic cyclodextrins using two-compartment mathematical model","volume":"2013","author":"Shityakov","year":"2013","journal-title":"Sci. World J."},{"issue":"8","key":"10.1016\/j.intimp.2024.113000_b0275","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/bms.1200070805","article-title":"Application of the stable isotope technique to the elucidation of the saturation phenomenon of nicardipine hydrochloride metabolizing enzyme activity in dogs","volume":"7","author":"Higuchi","year":"1980","journal-title":"Biomed. Mass Spectrom."},{"key":"10.1016\/j.intimp.2024.113000_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.reactfunctpolym.2023.105634","article-title":"Chitosan: a review on properties, biological activities and recent progress in biomedical applications","author":"Harugade","year":"2023","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.intimp.2024.113000_b0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00218","article-title":"Targeting of hepatic macrophages by therapeutic nanoparticles","volume":"11","author":"Colino","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113000_b0290","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s11671-018-2728-6","article-title":"Insight into cellular uptake and intracellular trafficking of nanoparticles","volume":"13","author":"Foroozandeh","year":"2018","journal-title":"Nanoscale Res. Lett."},{"issue":"1","key":"10.1016\/j.intimp.2024.113000_b0295","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1573403X10666140914160554","article-title":"Nanoparticles and the mononuclear phagocyte system: pharmacokinetics and applications for inflammatory diseases","volume":"10","author":"Song","year":"2014","journal-title":"Curr. Rheumatol. Rev."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924015212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924015212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T17:37:19Z","timestamp":1731087439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924015212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":59,"alternative-id":["S1567576924015212"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113000","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicardipine-chitosan nanoparticles alleviate thioacetamide-induced acute liver injury by targeting NF\u03baB\/NLRP3\/IL-1\u03b2 signaling in rats: Unraveling new roles beyond calcium channel blocking","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113000"}}